Provexis (PXS)

 

Latest News

Second Price Monitoring Extn

RNS Number: 3814W Provexis PLC 08 February 2017 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more than a pre-determined percen...

Price Monitoring Extension

RNS Number: 3809W Provexis PLC 08 February 2017 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occ...

Provexis narrows H1 pretax loss

Provexis has narrowed its H1 pretax loss to 139,617, from a loss of 228,447. Revenue improved to 123,456, from 40,908. "We re...

Half-year Report

RNS Number: 0321T Provexis PLC 30 December 2016 30 December 2016 Provexis plc UNAUDITED INTERIM RESULTS FOR SIX MONTHS TO 30 SEPTEMBER 2016 Provexis plc (" Provexis " or the " Company "), the business that develops, licenses and sells the proprietary, scientifically-proven Fruitflow heart-health functional food ingredient, announces its unaud...

All News

DateHeadlineSource
08-02-17Second Price Monitoring ExtnRNS
08-02-17Price Monitoring ExtensionRNS
30-12-16Provexis narrows H1 pretax lossStockMarketWire
30-12-16Half-year ReportRNS
21-12-16Second Price Monitoring ExtnRNS
21-12-16Price Monitoring ExtensionRNS
20-12-16FTSE supported by banks after MBNA acquisition StockMarketWire
20-12-16Weak commodity prices drag miners lowerStockMarketWire
20-12-16Provexis reports positive results from Fruitflow pilot study StockMarketWire
20-12-16Fruitflow and Blood Pressure - second stage updateRNS
01-12-16Has Provexis stopped the rot?Interactive Investor
30-11-16Trends and Targets for 1/12/2016Trends and Targets
23-11-16Study publication - comparison with aspirinRNS
18-11-16Mortgage data and commodity price weakness keeps FTSE in the redStockMarketWire
18-11-16New Collaboration for FruitflowRNS
30-09-16Result of AGMRNS
15-09-16Director/PDMR ShareholdingRNS
07-09-16Provexis reduces FY pretax lossStockMarketWire
07-09-16Preliminary ResultsRNS
02-09-16Holding(s) in CompanyRNS
02-08-16Provexis raises £224,000 at 0.24p/shareStockMarketWire
02-08-16Results of PlacingRNS
12-07-16Study PublicationRNS
29-06-16Funding UpdateRNS
29-06-16Product LaunchRNS
09-06-16Provexis in subscription talks StockMarketWire
09-06-16Funding UpdateRNS
31-05-16Trading UpdateRNS
11-04-16Second Price Monitoring ExtnRNS
11-04-16Price Monitoring ExtensionRNS
25-02-16Second Price Monitoring ExtnRNS
25-02-16Price Monitoring ExtensionRNS
19-02-16Second Price Monitoring ExtnRNS
19-02-16Price Monitoring ExtensionRNS
07-01-16Director Deals - Provexis PLC (PXS)StockMarketWire
07-01-16Director Deals - Provexis PLC (PXS)StockMarketWire
07-01-16Director/PDMR ShareholdingRNS
22-12-15Provexis widens H1 pretax lossStockMarketWire
22-12-15Half Yearly ReportRNS
30-09-15Result of AGMRNS

RSS feeds

  • Editorial news feed for LSE:PXS Editorial
  • Regulatory news feed for LSE:PXS Regulatory